Differential Developmental Trajectories for CB1 Cannabinoid Receptor Expression in Limbic/Associative and Sensorimotor Cortical Areas

被引:121
作者
Heng, Lijun [1 ]
Beverley, Joel A. [1 ]
Steiner, Heinz [1 ]
Tseng, Kuei Y. [1 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, N Chicago, IL 60064 USA
基金
美国国家卫生研究院;
关键词
adolescence; CB1 cannabinoid receptor; gene expression; prefrontal cortex; BRAIN-DEVELOPMENT; RAT-BRAIN; ENDOCANNABINOIDS; SCHIZOPHRENIA; DELTA-9-TETRAHYDROCANNABINOL; LOCALIZATION; ADOLESCENCE; ENVIRONMENT; MATURATION; CHILDHOOD;
D O I
10.1002/syn.20844
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabis use during adolescence is associated with an increased risk for schizophrenia and other disorders. The neuronal basis is unclear, but prefrontal cortical mechanisms have been implicated. Here, we investigated developmental changes in the endocannabinoid system by assessing expression and function of the CB1 cannabinoid receptor in prefrontal and other cortical areas in juvenile (postnatal day 25, P25), adolescent (P40), and adult (P70) rats. Overall, the expression of CB1 receptors in the cortex is highest in juveniles and drops thereafter toward adult levels. However, CB1 receptor expression follows distinct developmental trajectories in different cortical areas. The most pronounced and progressive decrease in CB1 expression was observed in medial prefrontal and other limbic/associative regions. In contrast, major changes in sensorimotor cortices occurred only after P40. We also assessed electrophysiological measures of CB1 receptor function and found that CB1-dependent inhibition of synaptic transmission in the prefrontal cortex follows the same developmental trajectory as observed for receptor expression. Together, these findings indicate that CB1 receptor-mediated signaling decreases during development but is differentially regulated in limbic/associative vs. sensorimotor systems. Therefore, cannabis use during adolescence likely differentially affects limbic/associative and sensorimotor cortical circuits. Synapse 65:278-286, 2011. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:278 / 286
页数:9
相关论文
共 40 条
[1]   Trajectories of brain development: point of vulnerability or window of opportunity? [J].
Andersen, SL .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2003, 27 (1-2) :3-18
[2]   Hardwiring the brain:: Endocannabinoids shape neuronal connectivity [J].
Berghuis, Paul ;
Rajnicek, Ann M. ;
Morozov, Yury M. ;
Ross, Ruth A. ;
Mulder, Jan ;
Urban, Gabriella M. ;
Monory, Krisztina ;
Marsicano, Giovanni ;
Matteoli, Michela ;
Canty, Alison ;
Irving, Andrew J. ;
Katona, Istvan ;
Yanagawa, Yuchio ;
Rakic, Pasko ;
Lutz, Beat ;
Mackie, Ken ;
Harkany, Tibor .
SCIENCE, 2007, 316 (5828) :1212-1216
[3]   Endocannabinoid signaling in rat somatosensory cortex:: Laminar differences and involvement of specific interneuron types [J].
Bodor, AL ;
Katona, I ;
Nyíri, G ;
Mackie, K ;
Ledent, C ;
Hájos, N ;
Freund, TF .
JOURNAL OF NEUROSCIENCE, 2005, 25 (29) :6845-6856
[4]   Neurodevelopmental changes in working memory and cognitive control [J].
Bunge, Silvia A. ;
Wright, Samantha B. .
CURRENT OPINION IN NEUROBIOLOGY, 2007, 17 (02) :243-250
[5]   Structural and functional brain development and its relation to cognitive development [J].
Casey, BJ ;
Giedd, JN ;
Thomas, KM .
BIOLOGICAL PSYCHOLOGY, 2000, 54 (1-3) :241-257
[6]   Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction [J].
Caspi, A ;
Moffitt, TE ;
Cannon, M ;
McClay, J ;
Murray, R ;
Harrington, H ;
Taylor, A ;
Arseneault, L ;
Williams, B ;
Braithwaite, A ;
Poulton, R ;
Craig, IW .
BIOLOGICAL PSYCHIATRY, 2005, 57 (10) :1117-1127
[7]   Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability [J].
Chambers, RA ;
Taylor, JR ;
Potenza, MN .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06) :1041-1052
[8]   Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction [J].
D'Souza, DC ;
Abi-Saab, WM ;
Madonick, S ;
Forselius-Bielen, K ;
Doersch, A ;
Braley, G ;
Gueorguieva, R ;
Cooper, TB ;
Krystal, JH .
BIOLOGICAL PSYCHIATRY, 2005, 57 (06) :594-608
[9]   The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis [J].
D'Souza, DC ;
Perry, E ;
MacDougall, L ;
Ammerman, Y ;
Cooper, T ;
Wu, YT ;
Braley, G ;
Gueorguieva, R ;
Krystal, JH .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (08) :1558-1572
[10]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605